Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells.
暂无分享,去创建一个
R. Dunn | S. Farr | M. Burczynski | M. McMillian | J. B. Parker | M. Johnson | J. Ciervo | L. Li | S. Hicken | R T Dunn | M E Burczynski | M D Johnson | M McMillian | J Ciervo | L Li | J B Parker | S Hicken | S Farr | Li Li | J. Parker | Joe Ciervo | Sam Hicken | Mark D. Johnson
[1] L. Hartwell,et al. Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae. , 2000, Cancer research.
[2] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[3] M. Adams,et al. Shotgun Sequencing of the Human Genome , 1998, Science.
[4] G. S. Johnson,et al. An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.
[5] R. Perona,et al. Lack of c‐Jun activity increases survival to cisplatin , 1999, FEBS letters.
[6] D. Botstein,et al. The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.
[7] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[9] P. Brown,et al. Drug target validation and identification of secondary drug target effects using DNA microarrays , 1998, Nature Medicine.
[10] E. Pennisi. Mouse Sequencers Take Up the Shotgun , 2000, Science.
[11] James L. Winkler,et al. Accessing Genetic Information with High-Density DNA Arrays , 1996, Science.
[12] E. Marshall. NIH to Produce a 'Working Draft' of the Genome by 2001 , 1998, Science.
[13] X. Sun,et al. Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression , 1995, Molecular and cellular biology.
[14] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[15] D. Morris,et al. Revolution through Genomics in Investigative and Discovery Toxicology , 1999, Toxicologic pathology.
[16] J. Trent,et al. Microarrays and toxicology: The advent of toxicogenomics , 1999, Molecular carcinogenesis.
[17] J. Castell,et al. Re‐expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells , 1998 .
[18] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[19] P. Galle,et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. , 1997, The Journal of clinical investigation.
[20] S. Deb,et al. Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter , 1995, Molecular and cellular biology.
[21] J. Barrett,et al. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. , 1999, Cancer research.
[22] M. Miura,et al. Resistance to Fas-mediated apoptosis: activation of Caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP , 1998, Oncogene.
[23] T. Jacks,et al. p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] R. Dunn,et al. Concise review: gene expression applied to toxicology. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[25] B. van de Water,et al. Endoplasmic Reticulum Stress Proteins Block Oxidant-induced Ca2+ Increases and Cell Death* , 1998, The Journal of Biological Chemistry.
[26] E. Pennisi. Finally, the Book of Life and Instructions for Navigating It , 2000, Science.
[27] Zohar Yakhini,et al. Clustering gene expression patterns , 1999, J. Comput. Biol..
[28] S. Aebi,et al. Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. , 1997, Cancer research.
[29] Ron Shamir,et al. Clustering Gene Expression Patterns , 1999, J. Comput. Biol..
[30] D. Botstein,et al. A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.
[31] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[32] E. Pennisi. Mouse Genome Added to Sequencing Effort , 1999, Science.
[33] P. Brown,et al. Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.
[34] Hiderou Yoshida,et al. Identification of the cis-Acting Endoplasmic Reticulum Stress Response Element Responsible for Transcriptional Induction of Mammalian Glucose-regulated Proteins , 1998, The Journal of Biological Chemistry.
[35] T. Bedilion,et al. The integration of microarray information in the drug development process. , 1998, Current opinion in biotechnology.
[36] P. Brown,et al. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. , 1996, Genome research.
[37] J. Aubrecht,et al. Molecular genotoxicity profiles of apoptosis-inducing vanadocene complexes. , 1999, Toxicology and applied pharmacology.